The Prescription for Change The need for compound
Post# of 7769
The need for compounding pharmacy services will continue to be vital to the delivery of quality healthcare and demand is expected to grow.
Industry at a Glance
Compounding Pharmacies in the US are expected to see revenues reach $5.3B and profits exceed an estimated $1.4B in 2014. According to IBISWorld report published earlier this year, industry revenue is forecasted to grow at an annualized rate of 3.5% to $6.2B in 2019.
SCRC is just beginning to take its place in this monstrous $5.3B compounding pharmacy market. Talk about the opportunity and the potential for future growth. With our current annual run rate, SCRC accounts for about 1% of this market. Mr. Schneiderman's decision to enter this market is a stroke of brilliance.
I wouldn't worry about the current PPS. SeeThruEquity sees the protential, Triumph Healthcare Finance sees the potential, Zack's sees the potential, and so do I. I truly believe by December 2015 we will all see this potential demonstrated in a PPS reflective of SCRC true success.